D-1080-2019 Class III Terminated
FDA drug recall D-1080-2019 was initiated by Akorn, Inc. on Mar 28, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing. The recall status is terminated (terminated Apr 22, 2020). Affected quantity: 2,796 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 10, 2019
- Initiation Date
- Mar 28, 2019
- Termination Date
- Apr 22, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,796 bottles
Product description
Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx only, HI-TECH Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-587-16
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.
Distribution pattern
AR and MS
Code information
Lot#: 356527, Exp 3/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1080-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026